Intuniv (guanfacine): Introduction and ADHD Overview

Uploaded by drugscom on 12.03.2012

Hello and welcome to "VideoScript", presented by
Today in the first of three presentations, we are reviewing Intuniv, generically known
as guanfacine.
Intuniv is an FDA-approved medication used as part of a treatment program to help manage
the symptoms of attention deficit hyperactivity disorder, or ADHD. Intuniv is approved for
use in children 6 to 17 years of age.
ADHD is a common behavioral disorder diagnosed in roughly 4 to 12 percent of school-aged
children. Boys are diagnosed about three times more often than girls.
Treatment of ADHD usually involves some combination of medications, counseling, behavior modification
and lifestyle changes. For young children 4 to 5 years of age, parent or teacher-administered
behavioral modification is the first treatment of choice.
Patients with ADHD have difficulty maintaining attention and completing tasks, and may show
signs of hyperactivity, impulsiveness, or some combination of these behaviors.
Intuniv can be used alone or in combination with stimulants, another class of medications
commonly used to treat ADHD. Intuniv comes as an extended-release formulation and is
given once daily.
Thank you for joining us at for a brief review of Intuniv. Please refer to
our patient and professional information, drug interaction checker, and additional tools
Patients with a concern about the use of Intuniv should consult with their health care provider.
Visit for more information